Electrical brain stimulation for early Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This study tests a non-invasive brain stimulation technique called transcranial alternating current stimulation (tACS) to see if it can improve memory and thinking in people with early Alzheimer's disease. It may offer a new way to help manage symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 90 years old.
- You have a diagnosis of mild cognitive impairment or mild dementia related to Alzheimer's disease, confirmed by tests like a brain scan or spinal fluid analysis.
- You score between 18 and 26 on a standard memory test (MMSE) and have a CDR score of 0.5 or 1.
- You can communicate in Chinese and are able to read and write.
- If you take Alzheimer's medication (like donepezil or rivastigmine), the dose has been stable for at least 6 weeks with no planned changes.
- You do not have other conditions that could cause cognitive problems, such as recent stroke, depression, or certain metal implants.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special type of brain stimulation called temporal interference stimulation can improve memory and thinking skills in people with early-stage Alzheimer's disease. The treatment uses electrical stimulation to target specific brain areas without surgery.
This trial studies a “closed-loop” brain stimulation approach to improve symptoms in people with early Alzheimer’s-related memory problems. It may help by delivering stimulation based on your brain signals, if you meet the safety and diagnosis requirements.
This study tests whether a gentle, noninvasive brain stimulation technique called tACS can help improve memory in people with Alzheimer's disease or mild cognitive impairment. It may also include healthy older adults for comparison.
This study tests whether a new type of brain stimulation (called repetitive transcranial magnetic stimulation, or rTMS) with a larger coil can improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves multiple sessions of rTMS and MRI scans.
This trial is testing whether a non-invasive brain stimulation treatment, called transcranial magnetic stimulation (using magnetic fields to activate brain cells), can help improve memory and thinking in people with Alzheimer's disease. It is a potential option for those looking to explore additional treatment approaches.
This trial tests a new, noninvasive treatment that combines magnetic and electrical stimulation to target a specific brain network in people with mild Alzheimer's disease. It aims to slow memory decline and improve brain function.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.